Global Startups Insights
Lets your startup
Funding News, Massachusetts, USA Startup Funding News

Robigo Raises Series A Funding to Advance Engineered Biopesticides

September 18, 2026
By
Loren Baker
Robigo Raises Series A Funding to Advance Engineered Biopesticides

Robigo, a Cambridge, Massachusetts-based biotechnology company developing biological solutions for crop protection, has raised an undisclosed amount in Series A funding.

The round was led by Leaps by Bayer, with participation from Illumina Ventures, SVG Thrive, Congruent Ventures, and Endeavor8.

How Robigo Will Use the Funding

Robigo will use the funding to accelerate the commercial launch of its engineered microbial biopesticides for fungal diseases affecting soybeans and specialty crops in the United States.

The company will also expand its pipeline to target additional soil-borne pathogens in broadacre crops, addressing an estimated $10 billion market.

Robigo’s Technology

Led by Founder and CEO Dr. Andee Wallace, Robigo uses synthetic biology to engineer living microbes for crop protection.

“At Robigo, we believe in building on nature’s foundation to engineer biological products that match or exceed the performance of today’s chemistries. Growers shouldn’t have to choose between a product that works and one that’s affordable or sustainable,” said Dr. Andee Wallace, Founder & CEO of Robigo.

“The scalability of the ARGO™ platform is what sets Robigo apart,” said Dr. Juergen Eckhardt, EVP and Head of Leaps by Bayer. “They are not just developing a single product but rather building an engine that can rapidly address diverse soil-borne pathogens across broadacre crops. Robigo’s pipeline of crop protection programs targets urgent, devastating diseases and offers a strong complement to Bayer’s crop protection portfolio. Robigo is moving quickly to provide farmers with the tools they need to protect their livelihoods, reduce environmental impact, and ensure a more resilient food system.”

Its ARGO™ platform uses computationally designed active ingredients to create new ways of controlling pathogens by silencing essential pathogen genes. The company says its technology can shorten development from design and microbe engineering to field testing to less than 20 months, compared with the typical three to five years in the industry.

Robigo’s engineered microbes are designed as a one-time treatment that continuously produces and delivers active ingredients where plants need them, providing season-long crop protection.

Targeting Crop Diseases

Robigo is developing solutions for major crop diseases, including Sudden Death Syndrome (SDS) in soybeans and fusarium wilt affecting lettuce and berry crops.

The company aims to provide biological crop protection solutions that can offer strong performance while supporting healthier soils and a more resilient food system.

Recommended Stories for You